GÜLDEN ANATACA
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Is Serum Irisin Level a Biomarker in Diabetic Polyneuropathy? (NCT07734597) | GÜLDEN ANATACA | 2026-07-30 |
| Evaluation of Serum Preptin Levels in Patients With Polycystic Ovary Syndrome (NCT07736079) | GÜLDEN ANATACA | 2026-07-30 |
| Evaluation of Neuregulin-4 (NRG4) Levels in Obese and Non-Obese Patients With Type 2 Diabetes Mellitus (NCT07734558) | GÜLDEN ANATACA | 2026-06-01 |
Track GÜLDEN ANATACA automatically
Every clearance here is in the API, with alerts when new ones post.